Metrohm Acquires B&W Tek
Pharmaceutical Technology's In the Lab eNewsletter
The acquisition will increase Metrohm’s spectroscopy offerings and capabilities.
On July 27, 2018, Metrohm AG, a manufacturer of high-precision instruments for chemical analysis, announced that it acquired B&W Tek’s spectroscopy solution business, B&W Tek, as well as several subsidiaries. B&W Tek is a provider of Raman spectroscopy solutions as well as laser-induced breakdown spectroscopy technology, near-infrared spectroscopy, and ultraviolet–visible spectroscopy/ultraviolet–visible spectrometers and solutions.
According to Metrohm, the acquisition contributes to the development of the company’s Raman product line as well as the company’s overall growth strategy. Financial details of the transaction were not disclosed.
B&W Tek will continue to operate under its own brand with its own sales and service organization for the time being to avoid any business disruption. After this transition period, B&W Tek will be gradually integrated into the Metrohm organization.
Source: Metrohm
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Shilpa Medicare Launches ‘Hybrid CDMO’ at DCAT Week 2025
March 17th 2025This model is being positioned by Shilpa as a dual approach that offers comprehensive discovery, clinical, and commercial outsourcing services in addition to commercially ready, “off-the-shelf” novel formulations for b2b licensing.
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.
